Loren Flynn PhD

Background. Inclusions of Sequestosome1 (SQSTM1/p62) within muscle fibers are a pathological hallmark of sporadic inclusion body myositis (sIBM) with p62 overexpression reported in patients. Mounting evidence suggests a role for p62 expression and/or variation in sIBM pathology, due to the presence of rare and potentially pathogenic missense variants (A117V, G194R, K238E, P392L). Consequently, we hypothesized that genetic modifiers of SQSTM1 may present a critical missing link for sIBM pathology and contribute to disease expres¬sion. Short structural variants (SSVs) are a class of genetic variation that can be difficult to characterized due to their highly repetitive and complex nature. Evidence that SSVs play an important role in complex diseases such as Alzhei¬mer’s Disease, Amyotrophic lateral sclerosis, Spinocerebellar Ataxia type 2, and Huntington’s disease is now confirmed and further investigations of this type of genetic variation is necessary to uncover missing heritability in complex dis¬eases. We and others have previously reported an SSV within SQSTM1 that is associated with altered expression of p62. The SSV rs60327661 is a CAAA in¬sertion/deletion within intron 5 of SQSTM1, which also confers risk for familial Amyotrophic lateral sclerosis. Due to the role of the SSV in Amyotrophic lateral sclerosis and altered p62 expression, we hypothesized the SSV rs60327661 may have disease-modifying effects in a longitudinal cohort of sIBM patients.

Methods. DNA samples from 218 sIBM patients and 242 healthy controls were received from The Institute for Immunology and Infectious Diseases, Murdoch, Western Australia, and the NINDS Repository, Coriell Institute for Medical Research, New Jersey. Genomic DNA samples were systematically assessed through polymerase chain reaction, capillary separation, and Sanger sequencing for rs60327661 allele genotyping.

Results: In the present study, when controlling for self-declared ancestry, car¬riage of the D/D genotype is associated with sIBM disease expression (p<0.05). Both the case and control groups did not violate Hardy-Weinberg equilibrium (p=0.99, p=0.98; respectively. Intriguingly, patients who were CN1A seroposi¬tive were more likely carry the D allele (n=18) when compared to patients with-out a D allele (n=3; p<0.047). Patients classified as fast progressors (n=2) carried only the D/D genotype.

Conclusion. In this study, we present the first report of an association between the SQSTM1 insertion/deletion and sIBM disease expression. We provide evi¬dence that the investigation of genetic variants outside of the HLA region is war¬ranted, and that such investigations are likely to uncover critical information for sIBM. We present the SSV rs60327661 as a novel disease modifying variant for sIBM which is functionally linked to p62 by altering protein expression. Our data adds to growing evidence that examination of SSVs may uncover novel genetic risk markers, and consequently further understanding of the pathogenic mechanisms at play.